Aether Industries has granted 1,77,996 stock options to eligible employees under its Employee Stock Option Scheme 2021 (ESOS 2021) at an exercise price of Rs 1,200 per option. The grant, approved by the Nomination and Remuneration Committee on July 8, 2026, covers options with a face value of Rs 10 each. The scheme is compliant with the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.

The options have been allotted under Tranche-10 to 377 grantees. The vesting schedule is structured over five years, with equal portions becoming eligible annually from July 8, 2028, to July 8, 2032. Upon vesting, employees are permitted to exercise the options within a period of two years from the date of vesting.

Vesting Schedule

The company confirmed that no options have been exercised, lapsed, or varied under this specific tranche. As the options are yet to be exercised, there is no current impact on the diluted earnings per share. The terms of the grants were finalized by the Nomination and Remuneration Committee in alignment with the existing scheme provisions.

Aether Industries has been downgraded to a Hold rating by InCred, with the brokerage setting a target price of ₹1,140. While the company demonstrates notable strengths across its specialty chemicals business, InCred's assessment indicates that current valuations and financial metrics constrain the scope for meaningful upside from present levels.

Downgrade Rationale

InCred's downgrade reflects a careful balancing of Aether Industries' operational strengths against key financial concerns. The brokerage points to rich valuations as a primary factor limiting the stock's upside, suggesting the market may have already priced in much of the company's growth potential. Compounding this, high capital expenditure intensity and weak return ratios further weigh on the investment case, making a more constructive stance difficult to justify at this stage.

Key Strengths Acknowledged

Despite the downgrade, InCred recognises several structural positives that underpin Aether Industries' business profile:

• Specialty chemical moats: The company benefits from well-established competitive advantages within the specialty chemicals space.
• Process expertise: Deep technical know-how in chemical synthesis and process development supports its market positioning.
• Sticky customer relationships: Long-standing client ties provide revenue visibility and reduce customer churn risk.
• Steady pharma intermediates growth: The pharmaceuticals intermediates segment continues to deliver consistent growth, anchoring the overall business.
• New platform diversification: Expansion into new chemical platforms offers avenues for future revenue diversification.

Valuation and Financial Concerns

The following table summarises the key factors cited by InCred in its Hold rating and target price assignment:

InCred's Hold call on Aether Industries reflects a nuanced view — one that does not dismiss the company's fundamental strengths but concludes that the current price adequately reflects these positives. The combination of elevated valuations, ongoing capital expenditure commitments, and subdued return metrics presents a cautious backdrop for investors evaluating the stock at this juncture.